It was said that weight loss drugs are a game converter. Turns out the benefits can be thinner than thought
Cleveland clinic researchers said Tuesday that conventional GLP -1 weight loss drugs, including Wegovy and Ozempic, may not be all in the “real world” environment. The reason is that patients may take lower doses or discontinue their treatment, adversely affect the ability to control blood sugar in those who are prefixed. Conclusions can affect people … Read more